ZMYM5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.188800E-01
Normal-vs-Stage2
9.169800E-01
Normal-vs-Stage3
2.000800E-01
Normal-vs-Stage4
1.879170E-01
Stage1-vs-Stage2
7.904600E-01
Stage1-vs-Stage3
4.954200E-02
Stage1-vs-Stage4
6.061600E-02
Stage2-vs-Stage3
1.858560E-01
Stage2-vs-Stage4
7.983400E-03
Stage3-vs-Stage4
2.376400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.638600E-01
Normal-vs-AfricanAmerican
3.311800E-01
Normal-vs-Asian
8.441600E-01
Caucasian-vs-AfricanAmerican
1.895810E-01
Caucasian-vs-Asian
7.342600E-01
AfricanAmerican-vs-Asian
3.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.399000E-01
Normal-vs-Female
7.403400E-01
Male-vs-Female
1.432580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.692600E-01
Normal-vs-Age(41-60Yrs)
8.293600E-01
Normal-vs-Age(61-80Yrs)
8.381000E-01
Normal-vs-Age(81-100Yrs)
7.688400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.224200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.788600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.577800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.258380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.463600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.726400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.447000E-01
Normal-vs-Daily Drinker
5.058200E-01
Normal-vs-Weekly Drinker
7.757000E-01
Normal-vs-Occasional Drinker
6.578600E-01
Normal-vs-Social Drinker
7.995000E-01
Non Drinker-vs-Daily Drinker
6.746400E-01
Non Drinker-vs-Weekly Drinker
9.605400E-01
Non Drinker-vs-Occasional Drinker
6.679900E-02
Non Drinker-vs-Social Drinker
6.922000E-01
Daily Drinker-vs-Weekly Drinker
7.388200E-01
Daily Drinker-vs-Occasional Drinker
3.675700E-02
Daily Drinker-vs-Social Drinker
4.555600E-01
Weekly Drinker-vs-Occasional Drinker
2.238000E-01
Weekly Drinker-vs-Social Drinker
8.195400E-01
Occasional Drinker-vs-Social Drinker
2.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.252000E-02
Normal-vs-Grade 2
3.842700E-03
Normal-vs-Grade 3
7.179700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.967210E-01
Grade 1-vs-Grade 3
2.568000E-01
Grade 1-vs-Grade 4
3.252000E-02
Grade 2-vs-Grade 3
9.649600E-01
Grade 2-vs-Grade 4
3.842700E-03
Grade 3-vs-Grade 4
7.179700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.216400E-01
Normal-vs-NonDiabetic
8.729400E-01
Diabetic-vs-NonDiabetic
7.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.004400E-01
Normal-vs-NoPancreatitis
8.766600E-01
Pancreatitis-vs-NoPancreatitis
7.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.622600E-01
Normal-vs-N1
8.956400E-01
N0-vs-N1
5.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.612800E-01
Normal-vs-TP53-NonMutant
8.299600E-01
TP53-Mutant-vs-TP53-NonMutant
3.532400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
